Aclaris Therapeutics ACRS
NASDAQ ACRS
$5.26 -0.02 (-0.38%)
At close: Sep 30, 2026 · 4:00 PM EDT

Aclaris Therapeutics (ACRS) Accounts Payables (2014 - 2026)

Updated

Aclaris Therapeutics' Accounts Payables came in at $15.52 million for Q2 2026, up 76.4% from $8.8 million a year earlier and up 5.3% from the prior quarter.

Analysis

Aclaris Therapeutics (ACRS) Accounts Payables (2014 - 2026) Analysis & Trends

At the end of FY2025, Aclaris Therapeutics' Accounts Payables was $13.16 million, up 180.6% from FY2024.

  • Accounts Payables carries a five-year compound annual growth rate of 20.2% (FY2020 to FY2025).
  • Going back by year, Accounts Payables was $4.69 million in FY2024 (-47.2%), $8.88 million in FY2023 (-14.2%), $10.35 million in FY2022 (+3.7%) and $9.99 million in FY2021 (+90.0%).
  • The Q2 2026 figure represents the highest quarterly Accounts Payables since Q3 2019.
  • Year-over-year, Accounts Payables has increased for five consecutive quarters, with growth averaging 40.1% over the last eight quarters.
  • The fastest year-over-year change in Accounts Payables over five years came in Q4 2025 (growth of 180.6%), and the weakest in Q4 2024 (a decline of 47.2%).
  • Business Quant data shows ACRS's Accounts Payables at $14.73 million (Q1 2026), $13.16 million (Q4 2025) and $9.19 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Aclaris Therapeutics 735.48 Mn 735.48 Mn 1.41 Mn 15.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.52 Mn
Mar 31, 2026 14.73 Mn
Dec 31, 2025 13.16 Mn
Sep 30, 2025 9.19 Mn
Jun 30, 2025 8.80 Mn
Mar 31, 2025 6.35 Mn
Dec 31, 2024 4.69 Mn
Sep 30, 2024 7.66 Mn
Jun 30, 2024 7.27 Mn
Mar 31, 2024 10.81 Mn
Dec 31, 2023 8.88 Mn
Sep 30, 2023 9.65 Mn
Jun 30, 2023 11.43 Mn
Mar 31, 2023 8.19 Mn
Dec 31, 2022 10.35 Mn
Sep 30, 2022 7.67 Mn
Jun 30, 2022 5.70 Mn
Mar 31, 2022 8.12 Mn
Dec 31, 2021 9.99 Mn
Sep 30, 2021 7.56 Mn
API Access

Aclaris Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=ACRS&period=max&api_key=YOUR_API_KEY